Is VSTM Worth Buying in 2026?

Verastem, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Verastem, Inc. (VSTM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.64% over 10 days); strong 1-year return of +14.4%. Concerns: trading below the 200-day MA (long-term downtrend); RSI 77 — overbought, elevated pullback risk. Currently 46.2% off its 52-week high. Score: +0/7.

Ready to act on this? 📈 Trade on Webull

VSTM is trading below its 200-day MA ($6.52) — a key warning sign the longer-term trend is under pressure. With an RSI of 77.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +14.4% compares to +16.5% for SPY (trailed the market by 2.1%). The current 46.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $11,437 today
vs. S&P 500 (SPY) — same period trailed market by 2.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($6.52)
Above 50-day MA ($4.53)
!RSI(14) neutral zone (30–70) — currently 77.0
Positive return (+14.4%)
!Within 10% of period high (−46.2%)
Period Range $6.05
$3.43 $11.25
RSI (14) 77.0
0 · OversoldOverbought · 100

Key Metrics

Price$6.05
Period Return+14.4%
Period High$11.25
Period Low$3.43
Drawdown−46.2%
MA-50$4.53
MA-200$6.52
RSI (14)77.0
Avg Volume (30d)2.9M
vs. SPYtrailed by 2.1%
Return Rank#411 of 999

Trade VSTM

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers